News
-
-
-
COMMUNIQUÉ DE PRESSE
BioVersys to report its half-year 2026 financial results, provide a business update and host a conference call
BioVersys AG to report half-year 2026 financial results, provide business update, and host conference call. Focus on novel antibacterial products for MDR bacteria infections -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
BioVersys AG announces approval of all Board Proposals at Annual General Meeting of Shareholders. Shareholders voted in favor of all Board proposals, including re-election of Board members and approval of compensation amounts -